WHO Slows Pace on Indigenous Health Strategy to Ensure ‘Meaningful’ Consent 06/02/2026 Felix Sassmannshausen The World Health Organization (WHO) has slowed the pace on the development of a Global Plan of Action to advance the health of indigenous peoples globally, with the Executive Board voting on Thursday to delay the plan’s final consideration until May 2027. The draft strategy aims to address the stark health inequities faced by many […] Continue reading -> Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> Latest US Restrictions on Aid ‘Bully’ Recipients to Accept ‘Extremist Ideology’ 29/01/2026 Kerry Cullinan Global health organisations have reacted with anger to the new US foreign aid policy, which prohibits all aid recipients, bar military, from performing or promoting abortion, “gender ideology”, or “diversity, equity and inclusion” (DEI). “Catastrophic”, “bullying”, “draconian” and “ideologically driven” – are some of their reactions to the Promoting Human Flourishing in Foreign Assistance (PHFFA) […] Continue reading -> Pandemic Agreement on Hold: Can Countries Bridge the Divide on Pathogen Access and Benefit Sharing? 27/01/2026 Daniela Morich Only 12 more negotiating days remain until WHO member states hit the May 2026 deadline for an agreement on a Pathogen Access and Benefit Sharing (PABS) system, as part of the new Pandemic Agreement adopted at last year’s World Health Assembly (WHA). The gap between developed and developing blocs of countries remains large, and progress […] Continue reading -> UN Agencies, Aid Groups Protest Israel’s Move to Bar Many NGOs from Gaza as Winter Exacerbates Dire Conditions 06/01/2026 Elaine Ruth Fletcher Senior United Nations officials and humanitarian leaders have urged Israel to reverse plans to withhold registration from more three-dozen international NGOs providing humanitarian relief in war-torn Gaza and the Israeli-occupied West Bank – warning that the move would severely undermine life-saving aid in a moment of acute humanitarian need. Israel said last Thursday that some […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> ‘Unprecedented Levels of Industry Interference’ Stalls Decisions on New Tobacco Products and Pollution at UNFCTC COP11 22/11/2025 Felix Sassmannshausen The Eleventh Conference of the Parties (COP) to the WHO Framework Convention on Tobacco Control (FCTC) concluded in Geneva on Saturday with calls to member states to take stronger action on reducing the environmental harm of tobacco use and increasing corporate liability. But political stand-offs between countries, along with industry interference, hindered major breakthroughs on […] Continue reading -> New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> From Texas to the G20: The Man Leading the World’s Brain Health Movement 31/10/2025 Maayan Hoffman As the G-20 Health Ministers meeting takes place next week in Johannesburg, South Africa, a new global coalition is trying to put Alzheimer’s and dementia-related diseases on the priority list of the world’s major economies; and there’s one man who stands out as a driving force behind this movement. In his video “Leadership Lessons from […] Continue reading -> Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy 04/02/2026 Felix Sassmannshausen A dispute over technology transfer rights pushed the World Health Organization (WHO) to delay its Global Action Plan on Antimicrobial Resistance (AMR) for further informal talks. Instead, the Executive Board approved a compromise drafted by Nepal and Ethiopia on Wednesday to reopen negotiations on intellectual property, specifically regarding “voluntary and mutually agreed technology transfers.” This […] Continue reading -> Latest US Restrictions on Aid ‘Bully’ Recipients to Accept ‘Extremist Ideology’ 29/01/2026 Kerry Cullinan Global health organisations have reacted with anger to the new US foreign aid policy, which prohibits all aid recipients, bar military, from performing or promoting abortion, “gender ideology”, or “diversity, equity and inclusion” (DEI). “Catastrophic”, “bullying”, “draconian” and “ideologically driven” – are some of their reactions to the Promoting Human Flourishing in Foreign Assistance (PHFFA) […] Continue reading -> Pandemic Agreement on Hold: Can Countries Bridge the Divide on Pathogen Access and Benefit Sharing? 27/01/2026 Daniela Morich Only 12 more negotiating days remain until WHO member states hit the May 2026 deadline for an agreement on a Pathogen Access and Benefit Sharing (PABS) system, as part of the new Pandemic Agreement adopted at last year’s World Health Assembly (WHA). The gap between developed and developing blocs of countries remains large, and progress […] Continue reading -> UN Agencies, Aid Groups Protest Israel’s Move to Bar Many NGOs from Gaza as Winter Exacerbates Dire Conditions 06/01/2026 Elaine Ruth Fletcher Senior United Nations officials and humanitarian leaders have urged Israel to reverse plans to withhold registration from more three-dozen international NGOs providing humanitarian relief in war-torn Gaza and the Israeli-occupied West Bank – warning that the move would severely undermine life-saving aid in a moment of acute humanitarian need. Israel said last Thursday that some […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> ‘Unprecedented Levels of Industry Interference’ Stalls Decisions on New Tobacco Products and Pollution at UNFCTC COP11 22/11/2025 Felix Sassmannshausen The Eleventh Conference of the Parties (COP) to the WHO Framework Convention on Tobacco Control (FCTC) concluded in Geneva on Saturday with calls to member states to take stronger action on reducing the environmental harm of tobacco use and increasing corporate liability. But political stand-offs between countries, along with industry interference, hindered major breakthroughs on […] Continue reading -> New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> From Texas to the G20: The Man Leading the World’s Brain Health Movement 31/10/2025 Maayan Hoffman As the G-20 Health Ministers meeting takes place next week in Johannesburg, South Africa, a new global coalition is trying to put Alzheimer’s and dementia-related diseases on the priority list of the world’s major economies; and there’s one man who stands out as a driving force behind this movement. In his video “Leadership Lessons from […] Continue reading -> Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Latest US Restrictions on Aid ‘Bully’ Recipients to Accept ‘Extremist Ideology’ 29/01/2026 Kerry Cullinan Global health organisations have reacted with anger to the new US foreign aid policy, which prohibits all aid recipients, bar military, from performing or promoting abortion, “gender ideology”, or “diversity, equity and inclusion” (DEI). “Catastrophic”, “bullying”, “draconian” and “ideologically driven” – are some of their reactions to the Promoting Human Flourishing in Foreign Assistance (PHFFA) […] Continue reading -> Pandemic Agreement on Hold: Can Countries Bridge the Divide on Pathogen Access and Benefit Sharing? 27/01/2026 Daniela Morich Only 12 more negotiating days remain until WHO member states hit the May 2026 deadline for an agreement on a Pathogen Access and Benefit Sharing (PABS) system, as part of the new Pandemic Agreement adopted at last year’s World Health Assembly (WHA). The gap between developed and developing blocs of countries remains large, and progress […] Continue reading -> UN Agencies, Aid Groups Protest Israel’s Move to Bar Many NGOs from Gaza as Winter Exacerbates Dire Conditions 06/01/2026 Elaine Ruth Fletcher Senior United Nations officials and humanitarian leaders have urged Israel to reverse plans to withhold registration from more three-dozen international NGOs providing humanitarian relief in war-torn Gaza and the Israeli-occupied West Bank – warning that the move would severely undermine life-saving aid in a moment of acute humanitarian need. Israel said last Thursday that some […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> ‘Unprecedented Levels of Industry Interference’ Stalls Decisions on New Tobacco Products and Pollution at UNFCTC COP11 22/11/2025 Felix Sassmannshausen The Eleventh Conference of the Parties (COP) to the WHO Framework Convention on Tobacco Control (FCTC) concluded in Geneva on Saturday with calls to member states to take stronger action on reducing the environmental harm of tobacco use and increasing corporate liability. But political stand-offs between countries, along with industry interference, hindered major breakthroughs on […] Continue reading -> New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> From Texas to the G20: The Man Leading the World’s Brain Health Movement 31/10/2025 Maayan Hoffman As the G-20 Health Ministers meeting takes place next week in Johannesburg, South Africa, a new global coalition is trying to put Alzheimer’s and dementia-related diseases on the priority list of the world’s major economies; and there’s one man who stands out as a driving force behind this movement. In his video “Leadership Lessons from […] Continue reading -> Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pandemic Agreement on Hold: Can Countries Bridge the Divide on Pathogen Access and Benefit Sharing? 27/01/2026 Daniela Morich Only 12 more negotiating days remain until WHO member states hit the May 2026 deadline for an agreement on a Pathogen Access and Benefit Sharing (PABS) system, as part of the new Pandemic Agreement adopted at last year’s World Health Assembly (WHA). The gap between developed and developing blocs of countries remains large, and progress […] Continue reading -> UN Agencies, Aid Groups Protest Israel’s Move to Bar Many NGOs from Gaza as Winter Exacerbates Dire Conditions 06/01/2026 Elaine Ruth Fletcher Senior United Nations officials and humanitarian leaders have urged Israel to reverse plans to withhold registration from more three-dozen international NGOs providing humanitarian relief in war-torn Gaza and the Israeli-occupied West Bank – warning that the move would severely undermine life-saving aid in a moment of acute humanitarian need. Israel said last Thursday that some […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> ‘Unprecedented Levels of Industry Interference’ Stalls Decisions on New Tobacco Products and Pollution at UNFCTC COP11 22/11/2025 Felix Sassmannshausen The Eleventh Conference of the Parties (COP) to the WHO Framework Convention on Tobacco Control (FCTC) concluded in Geneva on Saturday with calls to member states to take stronger action on reducing the environmental harm of tobacco use and increasing corporate liability. But political stand-offs between countries, along with industry interference, hindered major breakthroughs on […] Continue reading -> New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> From Texas to the G20: The Man Leading the World’s Brain Health Movement 31/10/2025 Maayan Hoffman As the G-20 Health Ministers meeting takes place next week in Johannesburg, South Africa, a new global coalition is trying to put Alzheimer’s and dementia-related diseases on the priority list of the world’s major economies; and there’s one man who stands out as a driving force behind this movement. In his video “Leadership Lessons from […] Continue reading -> Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
UN Agencies, Aid Groups Protest Israel’s Move to Bar Many NGOs from Gaza as Winter Exacerbates Dire Conditions 06/01/2026 Elaine Ruth Fletcher Senior United Nations officials and humanitarian leaders have urged Israel to reverse plans to withhold registration from more three-dozen international NGOs providing humanitarian relief in war-torn Gaza and the Israeli-occupied West Bank – warning that the move would severely undermine life-saving aid in a moment of acute humanitarian need. Israel said last Thursday that some […] Continue reading -> Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> ‘Unprecedented Levels of Industry Interference’ Stalls Decisions on New Tobacco Products and Pollution at UNFCTC COP11 22/11/2025 Felix Sassmannshausen The Eleventh Conference of the Parties (COP) to the WHO Framework Convention on Tobacco Control (FCTC) concluded in Geneva on Saturday with calls to member states to take stronger action on reducing the environmental harm of tobacco use and increasing corporate liability. But political stand-offs between countries, along with industry interference, hindered major breakthroughs on […] Continue reading -> New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> From Texas to the G20: The Man Leading the World’s Brain Health Movement 31/10/2025 Maayan Hoffman As the G-20 Health Ministers meeting takes place next week in Johannesburg, South Africa, a new global coalition is trying to put Alzheimer’s and dementia-related diseases on the priority list of the world’s major economies; and there’s one man who stands out as a driving force behind this movement. In his video “Leadership Lessons from […] Continue reading -> Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Infection Prevention and Control Falters Post-Pandemic – Increasing AMR Risks 04/12/2025 Elaine Ruth Fletcher The post-pandemic decline in infection-prevention practices, along with the broader crash in global health finance, are undermining progress against antimicrobial resistance – one of the planet’s most urgent health threats. At a recent panel discussion co-hosted by the Geneva Health Forum (GHF), leading experts from WHO, academia, biotech, and patient advocacy warned that national AMR plans […] Continue reading -> ‘Unprecedented Levels of Industry Interference’ Stalls Decisions on New Tobacco Products and Pollution at UNFCTC COP11 22/11/2025 Felix Sassmannshausen The Eleventh Conference of the Parties (COP) to the WHO Framework Convention on Tobacco Control (FCTC) concluded in Geneva on Saturday with calls to member states to take stronger action on reducing the environmental harm of tobacco use and increasing corporate liability. But political stand-offs between countries, along with industry interference, hindered major breakthroughs on […] Continue reading -> New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> From Texas to the G20: The Man Leading the World’s Brain Health Movement 31/10/2025 Maayan Hoffman As the G-20 Health Ministers meeting takes place next week in Johannesburg, South Africa, a new global coalition is trying to put Alzheimer’s and dementia-related diseases on the priority list of the world’s major economies; and there’s one man who stands out as a driving force behind this movement. In his video “Leadership Lessons from […] Continue reading -> Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘Unprecedented Levels of Industry Interference’ Stalls Decisions on New Tobacco Products and Pollution at UNFCTC COP11 22/11/2025 Felix Sassmannshausen The Eleventh Conference of the Parties (COP) to the WHO Framework Convention on Tobacco Control (FCTC) concluded in Geneva on Saturday with calls to member states to take stronger action on reducing the environmental harm of tobacco use and increasing corporate liability. But political stand-offs between countries, along with industry interference, hindered major breakthroughs on […] Continue reading -> New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> From Texas to the G20: The Man Leading the World’s Brain Health Movement 31/10/2025 Maayan Hoffman As the G-20 Health Ministers meeting takes place next week in Johannesburg, South Africa, a new global coalition is trying to put Alzheimer’s and dementia-related diseases on the priority list of the world’s major economies; and there’s one man who stands out as a driving force behind this movement. In his video “Leadership Lessons from […] Continue reading -> Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Malaria Drug Candidate Exceeds Cure Rate for Standard ACTs in Phase 3 Trial 12/11/2025 Felix Sassmannshausen The 97% cure rate for the novel compound, ganaplacide/lumefantrine in a recent Phase 3 trial offers hope for continued progress rolling back malaria even as resistance to artemisinin combination therapies (ACT) escalates. A next-generation antimalarial drug GanLum (ganaplacide/lumefantrine, KLU156) slightly outperformed a standard of care Artemisinin Combination Therapy (ACT) in a recent Phase 3 trial […] Continue reading -> From Texas to the G20: The Man Leading the World’s Brain Health Movement 31/10/2025 Maayan Hoffman As the G-20 Health Ministers meeting takes place next week in Johannesburg, South Africa, a new global coalition is trying to put Alzheimer’s and dementia-related diseases on the priority list of the world’s major economies; and there’s one man who stands out as a driving force behind this movement. In his video “Leadership Lessons from […] Continue reading -> Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
From Texas to the G20: The Man Leading the World’s Brain Health Movement 31/10/2025 Maayan Hoffman As the G-20 Health Ministers meeting takes place next week in Johannesburg, South Africa, a new global coalition is trying to put Alzheimer’s and dementia-related diseases on the priority list of the world’s major economies; and there’s one man who stands out as a driving force behind this movement. In his video “Leadership Lessons from […] Continue reading -> Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Looming Malaria Drug Resistance Spurs Global Search for New Treatments 10/10/2025 Felix Sassmannshausen Malaria affects millions worldwide, and progress against the disease is stalling. Emerging drug resistance threatens to reverse hard-won gains, putting many more lives at risk. Public–private partnerships are racing to close the treatment gap before the current drugs begin to fail. “We believe that the eradication of malaria is in sight, but it’s an ongoing […] Continue reading -> Posts navigation Older posts